Page 10 - Helix Laboratory Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Helix laboratory platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Helix Laboratory Platform Today - Breaking & Trending Today

Helix (HLIX) Achieves Market Cap of $15,762.74

Helix (HLIX) traded down 67.5% against the U.S. dollar during the 24 hour period ending at 8:00 AM Eastern on March 22nd. Helix has a total market cap of $15,762.74 and approximately $1.00 worth of Helix was traded on exchanges in the last 24 hours. During the last week, Helix has traded 58.4% lower against […] ....

Stronghands Masternode , Investment Coin , Hands Masternode , Currency Helix , Hlix Quark ,

Helix BioPharma Corp.: Helix Biopharma Corp. Announces Management and Board Changes

RICHMOND HILL, ON / ACCESSWIRE / March 22, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology ....

Richmond Hill , Artur Gabor , Adam Uszpolewicz , Frank Michalargias , Helix Biopharma Corp , Board Of Directors The Company , Audit Committee , Helix Biopharma , Chief Financial Officer , Chief Financial , Looking Statements ,

Helix BioPharma Corp.: Helix Biopharma Corp. Announces Unexpected Passing of Interim CEO and Chairman of the Board

RICHMOND HILL, ON / ACCESSWIRE / March 16, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company") today announces, with great sadness, the sudden passing of its Interim Chief Executive Officer ....

Richmond Hill , Artur Gabor , S Slawomir Majewski , Frank Michalargias , Head Of The Department Dermatology , Coordinator Of The Polish Center , International Relations , University Of Warsaw , Ministry Of Health , Helix Biopharma Corp , Warsaw Medical University , Helix Biopharma , Interim Chief Executive Officer , Interim Chief Executive , Deputy Rector , Medical University , Polish Center , Preclinical Studies , Scientific Advisory Board , Polish Ministry , Chief Executive , Chief Financial , Looking Statements , Annual Information Form ,

Helix BioPharma Corp.: Helix Biopharma Corp. Announces Fiscal 2022 Second Quarter Results

RICHMOND, ON / ACCESSWIRE / March 16, 2022 / Helix BioPharma Corp. (TSX:HBP), (" Helix " or the " Company "), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology ....

Richmond Hill , Frank Michalargias , Slawomir Majewski , Toronto Stock Exchange , Company Statements Of Financial Position , Drug Administration , Helix Biopharma Corp , Company Interim Condensed Financial , Board Of Directors The Company , Incentive Program , Helix Biopharma , Interim Chief Executive Officer , Chief Executive , Cello Healthcare , Consulting Management , Financial Position , Net Loss , Comprehensive Loss , Interim Condensed Financial Statements , Chief Financial , Looking Statements , Annual Information Form ,

Helix BioPharma Corp.: Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period

RICHMOND HILL, ON / ACCESSWIRE / March 11, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology ....

Richmond Hill , Frank Michalargias , Alpha Bronze , Toronto Stock Exchange , Helix Biopharma Corp , Incentive Program , Helix Biopharma , Incentive Plan , Jerzy Wilczewski , Interim Chief Executive , Multilateral Instrument , Minority Security Holders , Special Transactions , Eligible Warrants , Incentive Exercise Price , Extended Warrants , Warrant Extension , Chief Financial , Looking Statements , Chief Executive , Annual Information Form ,